Josh Hamilton,

DNP, APRN-BC, CTMH, CNE, CLNC, FAANP

Josh Hamilton,

DNP, APRN-BC, CTMH, CNE, CLNC, FAANP

Josh Hamilton,

DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC

Josh Hamilton, DNP, APRN-BC, CTMH, CNE, CLNC, FAANP, is in private practice in Las Vegas, where he serves patients via telebehavioral health in more than six states. With more than two decades of nursing experience, he also holds professorial appointments, leadership positions, and consults in higher education. Previously, he was associate medical director for the largest managed care behavioral health network in the desert Southwest. His professional interests include neurobiology, pharmacology, and epigenetics. He is an internationally recognized speaker on these and related topics at conferences and professional meetings. He served on the psychiatric medication working group at the Center of Excellence in Regulatory Science and Innovation, a FDA-sponsored project at the University of Maryland. He is a NEI Master Psychopharmacologist and a fellow of the American Association of Nurse Practitioners. Josh was America’s Top Psychiatric NP in 2021.

Josh's Shared Resources

Pandemic Disrupts LAI Antipsychotic Use in Schizophrenia Care

In 2020, the Sars-CoV-2 pandemic emerged as a significant global health crisis, with more than six million fatalities and nearly...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Survey Shows Clinician Hesitancy, Training Gaps in Long-Acting Injectables for Schizophrenia

This study assessed the use, attitudes, and obstacles regarding long-acting injectable (LAI) antipsychotic medications among U.S. psychiatric clinicians treating schizophrenia....
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Unlocking Social Cognition in Schizophrenia: Insights and Challenges

Social cognition is severely impaired in schizophrenia, leading to challenges in relationships and employment. Despite its critical role, understanding the...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Unraveling the Complexity of Schizophrenia: Insights from Genetics, Neuroimaging, and Neurobiology

Schizophrenia is a complex, chronic mental disorder marked by symptoms such as hallucinations, delusions, social withdrawal, and emotional flatness. Diagnosis...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Meta-Analysis Shows Major Cognitive Deficits in Treatment-Resistant Schizophrenia

Treatment-resistant schizophrenia (TRS) impacts roughly one-third of individuals diagnosed with schizophrenia, with 70-84% demonstrating resistance to treatment from the onset....
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP

Maintenance Electroconvulsive Therapy Proves Effective for Treatment-Resistant Schizophrenia

A recent study aimed to evaluate the efficacy and safety of maintenance electroconvulsive therapy (M-ECT) in patients with treatment-resistant schizophrenia...
CURATED BY:
Josh Hamilton,
DNP, APRN-BC, CTMH,
CNE, CLNC, FAANP
Share